Big Trade Sends Briacell Therapeutics Stock Higher

BCTX has almost doubled in 2021

Digital Content Manager
Dec 16, 2021 at 9:41 AM
facebook twitter linkedin

The shares of Briacell Therapeutics Corp (NASDAQ:BTCX) are up 6.8% at $8.53 this morning, following the company's announcement that an insider intends to acquire up to 1.59 million shares, which represents 10% of its public market securities. This purchase will commence on Jan. 31, 2022. 

BCTX is coming off an annual high of $12.47, hit on Dec. 1, but has since broken below long-time support at its 50-day moving average to touch a two month low of $7.06 earlier this week. The 120-day moving average provided support for this pullback, however, and today the stock is looking to rebound back towards that trendline. For the year, BCTX is up over 92%. 

This recent price action has put BCTX just on the cusp of being "oversold," too. This is per the equity's 14-day relative strength index (RSI) of 29, which indicates a short-term bounce could be in the cards. 

Short sellers have been piling on amid the pullback, with short interest rising 13.8% in the last reporting period. Should some of these bears change their tune, it could put wind at the stock's back, as the 1.88 million shares sold short make up a solid 15.9% of the stock's available float. 


Minimize Risk While Maximizing Profits

There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released! 



Special Offers from Schaeffer's Trading Partners